Sartorius AG (0NIQ) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Sartorius Ag.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0422f-54b7-7020-8c24-fcd5e0866e2b Created: 2026-08-27T07:46:36.715Z Duration: 4324.023 Channels: 1 00:00:00.000 -- 00:00:01.680 Ladies and gentlemen, 00:00:02.000 -- 00:00:05.440 welcome to the Sartorius and Sartorius Steadim Biotech 00:00:05.440 -- 00:00:08.880 Conference Call and Live Webcast on H1 2020 00:00:08.880 -- 00:00:11.920 six. I'm Moritz, your Chorus Call operator. I 00:00:11.920 -- 00:00:13.759 would like to remind you that all 00:00:27.550 -- 00:00:30.189 The conference must not be recorded for publication 00:00:30.189 -- 00:00:31.150 or broadcast. 00:00:31.310 -- 00:00:32.829 At this time, it's my pleasure to hand 00:00:32.829 -- 00:00:35.149 over to Petra Muller, Head of Investor Relations 00:00:35.149 -- 00:00:37.070 of Sartorius. Please go ahead. 00:00:38.110 -- 00:00:40.815 Thank you, and hello, and a warm welcome 00:00:40.815 -- 00:00:43.455 from my side. So today, I'm joined by 00:00:43.455 -- 00:00:46.415 our CEO, Michele Grosser by Florian Funk, our 00:00:46.415 -- 00:00:49.615 CFO by Rene Farber, Head of our Bioprocessing 00:00:49.615 -- 00:00:52.175 Division and CEO of Sartorius Stedim Biotech 00:00:52.500 -- 00:00:54.980 and also by Alexandra Gatzemaier, Head of our 00:00:54.980 -- 00:00:56.900 Lab Products and Services Division. 00:00:57.380 -- 00:00:59.620 As always, we will start with prepared remarks 00:00:59.620 -- 00:01:01.379 followed by the Q and A session. 00:01:01.700 -- 00:01:04.340 The call is scheduled to last one hour. 00:01:04.340 -- 00:01:06.979 As usual, please limit your questions to one, 00:01:07.475 -- 00:01:09.715 so that as many of you as possible 00:01:09.715 -- 00:01:10.835 can take part. 00:01:11.155 -- 00:01:13.155 In case we have some time at the 00:01:1...